Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.

Source: NYT Health - June 25, 2019 Category: Consumer Health News Authors: Michael J. de la Merced Tags: Allergan Inc Mergers, Acquisitions and Divestitures Drugs (Pharmaceuticals) AbbVie Inc Botox (Drug) Source Type: news